Active, Not Recruiting
A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors
NCT06777316
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +15 more
- Locations
-
- Stanford Cancer Institute Palo Alto, California, United States
- Mayo Clinic Jacksonville Jacksonville, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States